Examples: ICD M32, ICD R6521, ICD 8210, ICD 1970

C84Z - ICD 10 Diagnosis Code - Other mature T/NK-cell lymphomas - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians


Want to know more about Dexur's Capabilities? Get In Touch


ICD Code Description
C84Z0 Other mature T/NK-cell lymphomas, unspecified site
C84Z1 Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck
C84Z2 Other mature T/NK-cell lymphomas, intrathoracic lymph nodes
C84Z3 Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes
C84Z4 Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb
C84Z5 Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb
C84Z6 Other mature T/NK-cell lymphomas, intrapelvic lymph nodes
C84Z7 Other mature T/NK-cell lymphomas, spleen
C84Z8 Other mature T/NK-cell lymphomas, lymph nodes of multiple sites
C84Z9 Other mature T/NK-cell lymphomas, extranodal and solid organ sites

Hospitalizations with C84Z - Other mature T/NK-cell lymphomas - as a primary or secondary diagnosis code

  |  Back to Top

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

ICD Code ICD Description Total National Projected Hospitalizations - Annualized (Present on Admission - All) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) Total Medicare Hospitalization after Exclusion Avg. LOS Readmission Rate (%) Unplanned Readmission Rate (%) Total Medicare Payments Payment Per Day Payment Per Hospitalization Total Medicare Charges Avg. Charges Mortality Rate (%) SNF Discharge Rate (%) Home Discharge Rate (%)
C84Z9 Other mature T/NK-cell lymphomas, extranodal and solid organ sites 7.0 NA